KMT2A and leukemia: The high-risk genetic aberrations such as mixed lineage leukemia (MLL) gene rearrangements with chromosome 11q23 abnormality and the Philadelphia chromosome (BCR/ABL) were detected in 3 infants (3/45; 6.7%) and in 4/45 (8.8%) cases, respectively.